Does smoking cessation with varenicline worsen vascular endothelial function?

OBJECTIVES: A meta-analysis suggested that the use of varenicline, which is a partial agonist of nicotinic acetylcholine receptors and is effective in smoking cessation, increases the risk of cardiovascular events within 52 weeks of starting treatment. Defining these events as occurring during drug...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Umeda, Akira, Kato, Toru, Yamane, Tateki, Yano, Heiichi, Ieiri, Tamio, Miyagawa, Kazuya, Takeda, Hiroshi, Okada, Yasumasa
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2013
Assuntos:
Smoking and Tobacco
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3693419/
https://ncbi.nlm.nih.gov/pubmed/23794597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2013-003052
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados